Search Results - "Vilaro, Juan R."

Combination diuretic therapies in heart failure: Insights from GUIDE-IT by Budweg, Jeffery, Ahmed, Mustafa M., Vilaro, Juan R., Al-Ani, Mohammad A., Aranda, Juan M., Guo, Yi, Li, Ang, Patel, Sandip, Parker, Alex M.

“…Diuretics are the mainstay of maintaining and restoring euvolemia in the management of heart failure. Loop diuretics are often preferred, however, combination…”
Get full text

Artificial intelligence guidance of advanced heart failure therapies: A systematic scoping review by Al-Ani, Mohammad A, Bai, Chen, Hashky, Amal, Parker, Alex M, Vilaro, Juan R, Aranda, Jr, Juan M, Shickel, Benjamin, Rashidi, Parisa, Bihorac, Azra, Ahmed, Mustafa M, Mardini, Mamoun T

“…Artificial intelligence can recognize complex patterns in large datasets. It is a promising technology to advance heart failure practice, as many decisions…”
Get full text

Heart Failure with Preserved Ejection Fraction: Important Things to Know About the Stiff Heart by Vilaro, Juan R.

Get full text

Predictors of perioperative bleeding in left ventricular assist device implantation by Elzeneini, Mohammed, Mahmoud, Ahmad, Elsayed, Abdelrahman H., Taha, Yasmeen, Meece, Lauren E., Al-Ani, Mohammad, Jeng, Eric I., Arnaoutakis, George J., Vilaro, Juan R., Parker, Alex M., Aranda, Juan, Ahmed, Mustafa M.

“…Early bleeding is a common source of morbidity associated with left ventricular assist device (LVAD) implantation. Our objective was to identify potential…”
Get full text

Pharmacological Therapy Optimization for Heart Failure: A Practical Guide for the Internist by Dimza, Michelle, Kurup, Varsha, Canha, Catarina, Jimenez, Arlene, Al-Ani, Mohammad, Parker, Alex M., Vilaro, Juan R., Ahmed, Mustafa M., Aranda, Juan M.

“…Heart failure carries significant morbidity and mortality and affects a large population of patients cared for predominantly by primary care physicians. The…”
Get full text

Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma? by Stein, Andrew P, Matthia, Eldon L, Petty, Stephen A, Stewart, Brian, Vilaro, Juan R, Al-Ani, Mohammad A Z, Ahmed, Mustafa M, Aranda, Jr, Juan M, Hiemenz, John W, Parker, Alex M

“…We describe 2 challenging cases of cardiac transthyretin amyloidosis initially treated as cardiac amyloidosis light chain in the setting of active myeloma…”
Get full text

Utilization of the percutaneous left ventricular support as bridge to heart transplantation across the United States: In-depth UNOS database analysis by Al-Ani, Mohammad A., Bai, Chen, Bledsoe, Maisara, Ahmed, Mustafa M., Vilaro, Juan R., Parker, Alex M., Aranda, Juan M., Jeng, Eric, Shickel, Benjamin, Bihorac, Azra, Peek, Giles J., Bleiweis, Mark S., Jacobs, Jeffrey P., Mardini, Mamoun T.

“…Intra-aortic balloon pump (IABP) and Impella device utilization as a bridge to heart transplantation (HTx) have risen exponentially. We aimed to explore the…”
Get full text

Prognostic Value of Frailty for Heart Failure Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review by Meece, Lauren E., Yu, Julia, Winchester, David E., Petersen, Matthew, Jeng, Eric I., Al-Ani, Mohammad A., Parker, Alex M., Vilaro, Juan R., Aranda, Juan M., Ahmed, Mustafa M.

“…Frailty is associated with poor clinical outcomes in heart failure patients. The impact of frailty on outcomes following left ventricular assist device (LVAD)…”
Get full text

Stable Ischemic Heart Disease in the Older Adult by Vilaro, Juan R.

“…Demographic trends worldwide show a progressively aging population and an increase in the overall medical complexity of elderly patients with cardiovascular…”
Get full text

Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure by Elzeneini, Mohammed, Aranda, Juan M., Al-Ani, Mohammad, Ahmed, Mustafa M., Parker, Alex M., Vilaro, Juan R.

“…Intravenous inotropic therapy can be used in patients with advanced heart failure, as palliative therapy or as a bridge to cardiac transplantation or…”
Get full text

The quest for noninvasive predictors of pulmonary vascular resistance in heart transplant candidates by Parker, Alex M, Vilaro, Juan R, Kazory, Amir

Get more information

Left Ventricular Assist Device Use in Minorities: An Analysis of the National Inpatient Sample by Ahmed, Mustafa M, Meece, Lauren E, Guo, Yi, Jeng, Eric I, Parker, Alex M, Vilaro, Juan R, Al-Ani, Mohammad A, Aranda, Jr, Juan M

“…Minorities are less likely to receive a left ventricular assist device (LVAD). This, however, is based on total implant data. By examining rates of LVAD…”
Get full text

Impact of Laparoscopic Sleeve Gastrectomy on Cardiovascular Pharmacotherapy in Left Ventricular Assist Device Patients by Al-Ani, Mohammad A., Murray, Melissa R., Taha, Mohamad Badie, Meece, Lauren, Elsayed, Abdelrahman H., Jeng, Eric I., Arnaoutakis, George J., Wu, Yu, Friedman, Jeffrey E., Vilaro, Juan R., Parker, Alex M., Aranda, Juan M., Ahmed, Mustafa M.

“…Left ventricular assist device (LVAD) implantation is increasingly utilized in patients with advanced heart failure and morbid obesity. Laparoscopic sleeve…”
Get full text

Leadless pacemaker use in a patient with a durable left ventricular assist device by Parker, Alex M., Vilaro, Juan R., Aranda, Juan M., Al‐Ani, Mohammad, George, Phillip, Ahmed, Mustafa M.

“…There is limited known safety and efficacy of leadless pacemaker device use in patients with durable left ventricular assist devices (LVADs). We present a case…”
Get full text

A new opportunity for patient selection and optimization: Systematic review of cognitive frailty in patients undergoing left ventricular assist device implantation by Yu, Julia, Petersen, Matthew R., Meece, Lauren E., Jeng, Eric I., Al‐Ani, Mohammad A., Parker, Alex M., Vilaro, Juan R., Aranda, Juan M., Ahmed, Mustafa M.

“…The prognostic implication of cognitive frailty assessment in patients undergoing left ventricular assist device (LVAD) implantation remains unclear. We…”
Get full text

Reply: Advantage of leadless pacemaker over the conventional pacemaker in patients with left ventricular assist device by Parker, Alex M., Vilaro, Juan R., Aranda, Juan M., Al‐Ani, Mohammad, George, Phillip, Ahmed, Mustafa M.

Get full text

Current Management Strategies in Patients with Heart Failure and Atrial Fibrillation: A Review of the Literature by Parker, Alex M., Vilaro, Juan R., Ahmed, Mustafa M., Aranda, Juan M.

“…Heart Failure (HF) and Atrial Fibrillation (AF) are common diseases which lead to significant morbidity and mortality. Each disease can be a challenge to treat…”
Get full text

Heart Failure with Preserved Ejection Fraction: Time to Revisit the Stiff Heart by Vilaro, Juan R., Ahmed, Mustafa, Aranda, Juan M.

“…In the current era of cardiovascular disease, the diagnosis of heart failure with preserved ejection fraction (HFpEF) is a well-recognized clinical entity that…”
Get full text

Predictors of Early and Late Heart Failure Post-orthotopic Liver Transplantation by Al-Ani, Mohammad A, Lutfi, Forat G, Patel, Ameet P, Kullar, Vikas, Dolganiuc, Angela, Vilaro, Juan R, Firpi-Morell, Roberto J, Ahmed, Mustafa M

Get full text

Continuous Flow Left Ventricular Assist Device Therapy: A Focused Review on Optimal Patient Selection and Long-Term Follow-up Using Echocardiography by Juan R. Vilaro, Anita Szady, Mustafa M. Ahmed, Jacqueline Dawson, Juan M. Aranda

“…Despite widespread awareness and use of scientifically proven life-prolonging medical and device-based therapies over the last two decades, heart failure…”
Get full text